Teva logo

Teva's generic Saxenda (liraglutide) wins FDA approval, after its Victoza generic in 2024. Obesity drug market could nearly triple by 2030 with access, affordability & generics driving growth.

jcst2d.com/index.php/ne...

#Teva #GenericSaxenda #ObesityTreatment #FDAApproval #AccessToMedications